Published in
Elsevier, Contemporary Clinical Trials Communications, (8), p. 33-38, 2017
DOI: 10.1016/j.conctc.2017.08.012
Links
Tools
Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis
Journal article published in 2017 by
Anita D'Souza,
Kathryn Flynn 
,
Saurabh Chhabra,
Binod Dhakal,
Mehdi Hamadani ,
Kirsten Jacobsen,
Marcelo Pasquini,
Dorothee Weihrauch,
Parameswaran Hari
,
Saurabh Chhabra,
Binod Dhakal,
Mehdi Hamadani ,
Kirsten Jacobsen,
Marcelo Pasquini,
Dorothee Weihrauch,
Parameswaran Hari
This paper is made freely available by the publisher.
Full text: Download
Data provided by 